MARK DAVIS: Open Payments
NPI 1487747713 · SHAWNEE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 64 payments from 12 companies in 2025. Trend: 2023 $55 · 2024 $194 · 2025 $994
Food & beverage: $994
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 20 | $200 |
| Baxter Healthcare | 10 | $158 |
| Viatris Specialty LLC | 10 | $155 |
| Regeneron Healthcare Solutions, Inc. | 6 | $152 |
| Amgen Inc. | 4 | $78 |
| GENZYME CORPORATION | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Verona Pharma, Inc. | 2 | $30 |
| Philips North America LLC | 2 | $28 |
Products named: DUPIXENT, NUCALA, Hillrom - Monarch Airway Clearance System, YUPELRI, TEZSPIRE, FASENRA, Ohtuvayre, Vest Therapy Und.
Industry payments across OK — which companies pay providers there.
